number of access : ?
number of downloads : ?
ID 116349
Author
Bando, Hiroshi Tokushima University|Japan Low Carbohydrate Diet Promotion Association|Sakamoto Hospital KAKEN Search Researchers
Iwatsuki, Noboru Sakamoto Hospital
Sakamoto, Kazuki Sakamoto Hospital
Ogawa, Tomoya Sakamoto Hospital
Keywords
Xultophy
Insulin Degludec and Liraglutide
Type 2 Diabetes Mellitus
Meal Tolerance Test
Postprandial Hyperglycemia
Content Type
Journal Article
Description
The case is a 69-year-old male patient with Type 2 Diabetes Mellitus (T2DM) for 21 years. His diabetic control was not so satisfactory, and his HbA1c value increased in spring 2021. Then, he started Xultophy (IDegLira), which includes a fixed ratio of two agents of basal degludec and liraglutide. Just after providing Xultophy, the daily profile of blood glucose decreased from 179-400 mg/dL to 112-171 mg/dL, with remarkable clinical efficacy. He usually takes 80g of carbohydrates in breakfast, and the meal tolerance test (MTT) was challenged. As carbohydrate loading was given 100-75-50-0%, postprandial hyperglycemia at 60-min showed 277-219-159-133 mg/dL, respectively.
Journal Title
Asploro Journal of Biomedical and Clinical Case Reports
ISSN
25820370
Publisher
Asploro
Volume
4
Issue
2
Start Page
145
End Page
152
Published Date
2021-08-12
Rights
This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences